siRNA
HORIZON DISCOVERY BIOSCIENCES LIMITED ONTARGET HDAC9 HMN SP 5NMOL
NC3870898 ONTARGET HDAC9 HMN SP 5NMOL
Medchemexpress LLC GalNac-siRNA negative control (21nt) | 1 MG
GalNac-siRNA negative control (21nt) is the negative control form of GalNac-siRNA, an Asialoglycoprotein receptor (ASGPR)-targeted inhibitor conjugate. It is used in research for conditions such as hereditary transthyretin amyloidosis, acute hepatic porphyria, hemophilia, and hypercholesterolemia. This product is a solid, white to off-white substance.
- Negative control for GalNac-siRNA
- Targets Asialoglycoprotein receptor (ASGPR)
- Used in research for various conditions
- Solid, white to off-white appearance
- Purity of 99.09%
- Stable under recommended storage conditions
HORIZON DISCOVERY BIOSCIENCES LIMITED ON-TARGETPLUS GAPD CONTROL SIR
ON-TARGETplus GAPD Control siRNA (Human
HORIZON DISCOVERY BIOSCIENCES LIMITED Accell siRNA Delivery Media
Accell siRNA Delivery Media is a serum-free and antibiotic-free media designed for efficient delivery of Accell siRNA into difficult-to-transfect cells without the need for transfection reagents or complex delivery protocols. It contains a proprietary formulation of lipids, proteins and other components that enables passive uptake of siRNA for gene knockdown studies. This media is compatible with both suspension and adherent cell types. It simplifies siRNA delivery, reduces non-specific effects and toxicity and improves gene silencing efficiency.
ABclonal Technology KD Validated DYNC1H1
Dyneins are a group of microtubule-activated ATPases that function as molecular motors They are divided into two subgroups of axonemal and cytoplasmic dyneins The cytoplasmic dyneins function in intracellular motility including retrograde axonal transport protein sorting organelle movement and spindle dynamics Molecules of conventional cytoplasmic dynein are comprised of 2 heavy chain polypeptides and a number of intermediate and light chains This gene encodes a member of the cytoplasmic dynein heavy chain family
Abcam SB 202190, cell-permeable p38 MAPK inhibitor, 50MG
MW 331.3 Da, Purity >99%. Highly selective, potent and cell-permeable p38 MAPK inhibitor (IC₅₀ values are 50 and 100 nM at SAPK2a/p38 and SAPK2b/p38β2, respectively). Selective over a wide range of other kinases. Apoptosis and autophagy inducer. 3D Growth matrix component and additive for long term growth; also component of gastric organoid culture media.
The product is subject to the following: Abcam Restricted Use Statement
Sigma Aldrich Fine Chemicals Biosciences PI3 Kinase p110alpha/p85al
Product Source Coexpressed by baculovirus in Sf21 insect cells